Safety and activity of the IL-15/sIL-15Rα complex ALT-803 in combination with the anti-PD1 mAb nivolumab in metastatic non-small cell lung cancerCLINICAL CANCER RESEARCHIF10.22018-09-010PRE
Safety and activity of the IL-15/sIL-15Rα complex ALT-803 in combination with the anti-PD1 mAb nivolumab in metastatic non-small cell lung cancerCLINICAL CANCER RESEARCHIF10.22018-09-010PRE
未登录.png){kind=icon}
未登录
